Interview with the Innovators

Best Practices: Evolving Understanding of Molecular Diagnostics and Biomarkers in Lung Cancer

Lauren Ritterhouse, MD, PhD; Geoff Oxnard, MD

September 2018, Vol 8, No 9 - 2018 ASCO, Interview with the Innovators

At ASCO 2018, Oncology Practice Management (OPM) discussed the current state of genetics and genomic testing, the increasing understanding of biomarkers, and how they influence the treatment of patients with lung cancer. The discussion highlighted the interaction between oncologists and pathologists to facilitate best outcomes for patients. This interview included Lauren Ritterhouse, MD, PhD, Co-Director, Clinical Genomics Lab, University of Chicago, IL, and Geoff Oxnard, MD, Thoracic Oncologist, Dana-Farber Cancer Institute, and Associate Professor of Medicine, Harvard Medical School, Boston, MA. [ Read More ]

Best Practices: Use of Biomarkers in the Treatment of Patients with Lung Cancer

Roy S. Herbst, MD, PhD; David L. Rimm, MD, PhD

August 2018, Vol 8, No 8 - 2018 ASCO, Interview with the Innovators

At ASCO 2018, Oncology Practice Management (OPM) spoke with Roy S. Herbst, MD, PhD, Chief of Medical Oncology and Associate Director for Translational Research at Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT, and David L. Rimm, MD, PhD, Professor of Pathology, Yale University School of Medicine, about the increasing role of biomarkers in the management of patients with lung cancer. [ Read More ]